Kevin J. Ballinger, EVP & President, Interven Cardio at BOSTON SCIENTIFIC CORP (BSX), sold 105,216 shares at $35.87 ($3.7M) on 2018-06-11, disclosed to the SEC on 2018-06-13.
Open-market sale of $3.7M BSX by EVP & President, Interven Cardio. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.00 | 31,056 | $994K | 27.2% |
| 2 | $35.87 | 36,730 | $1.3M | 36.1% |
| 3 | $35.87 | 36,730 | $1.3M | 36.1% |
| 4 | $36.77 | 700 | $26K | 0.7% |
| Total | $34.73 avg | 105,216 | $3.7M | 100% |
| Filing → |
| BSX | SELL | 2020-03-03 | $1.2M | — | Filing → |
| BSX | SELL | 2020-02-26 | $466K | — | Filing → |
| BSX | SELL | 2020-02-19 | $149K | — | Filing → |